BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 36056180)

  • 21. Imaging of cancer predisposition syndromes in children.
    Monsalve J; Kapur J; Malkin D; Babyn PS
    Radiographics; 2011; 31(1):263-80. PubMed ID: 21257945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicians Practicing Obstetrics and Gynecology Are Uniquely Situated to Recognize DICER1 Syndrome.
    Hayes KG; French AV
    J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):780-782. PubMed ID: 34284081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic insights into familial tumors of the nervous system.
    Melean G; Sestini R; Ammannati F; Papi L
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):74-84. PubMed ID: 15264275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the central nervous system manifestations of DICER1 syndrome.
    de Kock L; Priest JR; Foulkes WD; Alexandrescu S
    Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain and/or Spinal Cord Tumors Accompanied with Other Diseases or Syndromes.
    Capitanio JF; Mortini P
    Adv Exp Med Biol; 2023; 1405():645-672. PubMed ID: 37452957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic predisposition to childhood cancer].
    Ripperger T; Schlegelberger B
    Pathologe; 2018 Dec; 39(Suppl 2):306-310. PubMed ID: 30397787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary ovarian tumour syndromes: current update on genetics and imaging.
    Shanbhogue KP; Prasad AS; Ucisik-Keser FE; Katabathina VS; Morani AC
    Clin Radiol; 2021 Apr; 76(4):313.e15-313.e26. PubMed ID: 33353730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
    Wimmer K; Rosenbaum T; Messiaen L
    Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.
    Mork ME; You YN; Ying J; Bannon SA; Lynch PM; Rodriguez-Bigas MA; Vilar E
    J Clin Oncol; 2015 Nov; 33(31):3544-9. PubMed ID: 26195711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary tumor syndromes of the nervous system: overview and rare syndromes.
    Louis DN; von Deimling A
    Brain Pathol; 1995 Apr; 5(2):145-51. PubMed ID: 7670655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Schultz KAP; Rednam SP; Kamihara J; Doros L; Achatz MI; Wasserman JD; Diller LR; Brugières L; Druker H; Schneider KA; McGee RB; Foulkes WD
    Clin Cancer Res; 2017 Jun; 23(12):e76-e82. PubMed ID: 28620008
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurooncology of familial cancer syndromes.
    Hottinger AF; Khakoo Y
    J Child Neurol; 2009 Dec; 24(12):1526-35. PubMed ID: 19955345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
    Kalkan E; Waguespack SG
    Front Horm Res; 2013; 41():166-81. PubMed ID: 23652677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.
    Mitchell SG; Pencheva B; Porter CC
    Curr Oncol Rep; 2019 Aug; 21(10):85. PubMed ID: 31414239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations.
    Bardón-Cancho EJ; Haro-Díaz A; Alonso-García-de la Rosa FJ; Huerta-Aragonés J; García-Morín M; González-Martínez F; Garrido-Colino C
    Fam Cancer; 2017 Apr; 16(2):291-294. PubMed ID: 27830405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
    Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
    Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D
    JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.